Atlas Trials

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Clinical trial NCT07500805 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07500805
Sponsor
UTC Therapeutics Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
CD70-positive Advanced Renal Clear Cell Carcinoma
Start date
2026-05-01
Primary completion
2028-05-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.